+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report by Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), End-use (Hospitals, Homecare), Country with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 80 Pages
  • May 2025
  • Region: North America
  • Grand View Research
  • ID: 6098216
The North America Syringe Infusion Pumps Market was valued at USD 645.1 million in 2024, and is projected to reach USD 1.04 billion by 2030, rising at a CAGR of 8.40%. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes.

The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by 2035.

Technological advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the market.

North America Syringe Infusion Pumps Market Report Highlights:

  • Pediatrics/neonatology held the largest revenue share of over 25.0% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments
  • The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period
  • Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases.
  • Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications.
  • Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period.
  • The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease Indication
1.2.2. End Use
1.2.3. Country scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease indication outlook
2.2.2. End use outlook
2.2.3. Country outlook
2.3. Competitive Insights
Chapter 3. North America Syringe Infusion Pumps Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. North America Syringe Infusion Pumps Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. North America Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis
4.1. Disease Indication Segment Dashboard
4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis
4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
4.4. Chemotherapy
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Diabetes
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Gastroenterology
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Analgesia/Pain Management
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Pediatrics/Neonatology
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Hematology
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Others
4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. North America Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis
5.1. End Use Segment Dashboard
5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis
5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Homecare
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. North America Syringe Infusion Pumps Market: Country Estimates & Trend Analysis
6.1. Country Market Dashboard
6.2. Country Market Share Analysis, 2024 & 2030
6.3. North America Syringe Infusion Pumps Market by country: Key Takeaways
6.4. U.S.
6.4.1. Key country dynamics
6.4.2. Regulatory framework/ reimbursement structure
6.4.3. Competitive scenario
6.4.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Canada
6.5.1. Key country dynamics
6.5.2. Regulatory framework/ reimbursement structure
6.5.3. Competitive scenario
6.5.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Mexico
6.6.1. Key country dynamics
6.6.2. Regulatory framework/ reimbursement structure
6.6.3. Competitive scenario
6.6.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
7.4.1. Baxter
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. B. Braun Medical Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Fresenius Kabi AG
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. ICU Medical, Inc.
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Micrel Medical Devices SA
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Boston Scientific Corporation
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. BD
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Terumo Corporation
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Moog Inc.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. IRadimed Corporation
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. CODAN Companies
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. ACROMED
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America syringe infusion pumps market, by country, 2018-2030 (USD Million)
Table 3 North America syringe infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 4 North America syringe infusion pumps market, by end use, 2018-2030 (USD Million)
Table 5 U.S. syringe infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 6 U.S. syringe infusion pumps market, by end use, 2018-2030 (USD Million)
Table 7 Canada syringe infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 8 Canada syringe infusion pumps market, by end use, 2018-2030 (USD Million)
Table 9 Mexico syringe infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 10 Mexico surgical ablation market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 North America syringe infusion pumps market: market outlook
Figure 10 North America syringe infusion pumps competitive insights
Figure 11 Parent market outlook
Figure 12 Related/ancillary market outlook
Figure 13 Penetration and growth prospect mapping
Figure 14 Industry value chain analysis
Figure 15 North America syringe infusion pumps market driver impact
Figure 16 North America syringe infusion pumps market restraint impact
Figure 17 North America syringe infusion pumps market strategic initiatives analysis
Figure 18 North America syringe infusion pumps market: Disease indication movement analysis
Figure 19 North America syringe infusion pumps market: Disease indication outlook and key takeaways
Figure 20 Chemotherapy estimates and forecast, 2018-2030
Figure 21 Diabetes estimates and forecast, 2018-2030
Figure 22 Gastroenterology estimates and forecast, 2018-2030
Figure 23 Analgesia/Pain management estimates and forecast, 2018-2030
Figure 24 Pediatrics/Neonatology estimates and forecast, 2018-2030
Figure 25 Hematology estimates and forecast, 2018-2030
Figure 26 Others estimates and forecast, 2018-2030
Figure 27 North America syringe infusion pumps market: End use movement analysis
Figure 28 North America syringe infusion pumps market: End use outlook and key takeaways
Figure 29 Hospitals estimates and forecast, 2018-2030
Figure 30 Homecare estimates and forecast, 2018-2030
Figure 31 Others (ASC, nursing homes, rehabilitation centers) estimates and forecast, 2018-2030
Figure 32 North America syringe infusion pumps market: Country movement analysis
Figure 33 North America syringe infusion pumps market: Country outlook and key takeaways
Figure 34 U.S. market estimates and forecasts, 2018-2030
Figure 35 Canada market estimates and forecasts, 2018-2030
Figure 36 Mexico market estimates and forecasts, 2018-2030

Companies Mentioned

The major companies featured in this North America Syringe Infusion Pumps market report include:
  • Baxter
  • B. Braun Medical Inc.
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • Micrel Medical Devices SA
  • Boston Scientific Corporation
  • BD
  • Terumo Corporation
  • Moog Inc.
  • IRadimed Corporation
  • CODAN Companies
  • ACROMED

Table Information